Yayın: Anti-tumour necrosis factor-alpha treatment of juvenile idiopathic arthritis in a patient with common variable immunodeficiency
| dc.contributor.buuauthor | Kılıç, Sara Şebnem | |
| dc.contributor.department | Tıp Fakültesi | |
| dc.contributor.department | Çocuk Sağlığı ve Hastalıkları Ana Bilim Dalı | |
| dc.contributor.orcid | 0000-0001-8571-2581 | |
| dc.contributor.researcherid | AAH-1658-2021 | |
| dc.contributor.scopusid | 34975059200 | |
| dc.date.accessioned | 2022-03-07T08:54:06Z | |
| dc.date.available | 2022-03-07T08:54:06Z | |
| dc.date.issued | 2005-06 | |
| dc.identifier.citation | Kılıç, S. Ş. (2005). "Anti-tumour necrosis factor-alpha treatment of juvenile idiopathic arthritis in a patient with common variable immunodeficiency". Journal of Tropical Pediatrics, 51(3), 194-195. | |
| dc.identifier.doi | 10.1093/tropej/fmi027 | |
| dc.identifier.endpage | 195 | |
| dc.identifier.issn | 0142-6338 | |
| dc.identifier.issue | 3 | |
| dc.identifier.pubmed | 15855303 | |
| dc.identifier.scopus | 2-s2.0-23944526940 | |
| dc.identifier.startpage | 194 | |
| dc.identifier.uri | https://doi.org/10.1093/tropej/fmi027 | |
| dc.identifier.uri | https://academic.oup.com/tropej/article/51/3/194/1646327 | |
| dc.identifier.uri | http://hdl.handle.net/11452/24866 | |
| dc.identifier.volume | 51 | |
| dc.identifier.wos | 000229545200014 | |
| dc.indexed.scopus | Scopus | |
| dc.indexed.wos | SCIE | |
| dc.language.iso | en | |
| dc.publisher | Oxford University Press | |
| dc.relation.journal | Journal of Tropical Pediatrics | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | Pediatrics | |
| dc.subject | Tropical medicine | |
| dc.subject | Rheumatoid-arthritis | |
| dc.subject.emtree | Antirheumatic agent | |
| dc.subject.emtree | Corticosteroid derivative | |
| dc.subject.emtree | Immunoglobulin | |
| dc.subject.emtree | Infliximab | |
| dc.subject.emtree | Methotrexate | |
| dc.subject.emtree | Nonsteroid antiinflammatory agent | |
| dc.subject.emtree | Tumor necrosis factor | |
| dc.subject.emtree | Tumor necrosis factor alpha | |
| dc.subject.emtree | Antirheumatic agent | |
| dc.subject.emtree | Infliximab | |
| dc.subject.emtree | Monoclonal antibody | |
| dc.subject.emtree | Case report | |
| dc.subject.emtree | Clinical feature | |
| dc.subject.emtree | Clinical trial | |
| dc.subject.emtree | Common variable immunodeficiency | |
| dc.subject.emtree | Demyelination | |
| dc.subject.emtree | Disease exacerbation | |
| dc.subject.emtree | Drug hypersensitivity | |
| dc.subject.emtree | Drug infusion | |
| dc.subject.emtree | Drug infusion reaction | |
| dc.subject.emtree | Elbow disease | |
| dc.subject.emtree | Fever | |
| dc.subject.emtree | Fibrosing alveolitis | |
| dc.subject.emtree | Follow up | |
| dc.subject.emtree | Human | |
| dc.subject.emtree | Immunological parameters | |
| dc.subject.emtree | Infection | |
| dc.subject.emtree | Juvenile rheumatoid arthritis | |
| dc.subject.emtree | Knee arthritis | |
| dc.subject.emtree | Knee pain | |
| dc.subject.emtree | Laboratory test | |
| dc.subject.emtree | Letter | |
| dc.subject.emtree | Male | |
| dc.subject.emtree | Malignant neoplastic disease | |
| dc.subject.emtree | Physical examination | |
| dc.subject.emtree | School child | |
| dc.subject.emtree | Splenomegaly | |
| dc.subject.emtree | Treatment outcome | |
| dc.subject.emtree | Tuberculosis | |
| dc.subject.emtree | Article | |
| dc.subject.emtree | Child | |
| dc.subject.emtree | Common variable immunodeficiency | |
| dc.subject.emtree | Dose response | |
| dc.subject.emtree | Drug administration | |
| dc.subject.emtree | Hospitalization | |
| dc.subject.emtree | Immunology | |
| dc.subject.emtree | Risk assessment | |
| dc.subject.mesh | Antibodies, monoclonal | |
| dc.subject.mesh | Antirheumatic agents | |
| dc.subject.mesh | Arthritis, juvenile rheumatoid | |
| dc.subject.mesh | Child | |
| dc.subject.mesh | Common variable immunodeficiency | |
| dc.subject.mesh | Dose-response relationship, drug | |
| dc.subject.mesh | Drug administration schedule | |
| dc.subject.mesh | Follow-up studies | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Male | |
| dc.subject.mesh | Risk assessment | |
| dc.subject.mesh | Severity of illness index | |
| dc.subject.mesh | Treatment outcome | |
| dc.subject.scopus | Common Variable Immunodeficiency; Immunoglobulin Deficiency; Immunosuppression | |
| dc.subject.wos | Pediatrics | |
| dc.subject.wos | Tropical medicine | |
| dc.title | Anti-tumour necrosis factor-alpha treatment of juvenile idiopathic arthritis in a patient with common variable immunodeficiency | |
| dc.type | Article | |
| dc.wos.quartile | Q3 | |
| dc.wos.quartile | Q3 | |
| dspace.entity.type | Publication | |
| local.contributor.department | Tıp Fakültesi/Çocuk Sağlığı ve Hastalıkları Ana Bilim Dalı | |
| local.indexed.at | PubMed | |
| local.indexed.at | WOS | |
| local.indexed.at | Scopus |
